Citation: Pm. Lea et Ai. Faden, Traumatic brain injury: Developmental differences in glutamate receptor response and the impact on treatment, MENT RET D, 7(4), 2001, pp. 235-248
Authors:
Yakovlev, AG
Di, X
Movsesyan, V
Mullins, PGM
Wang, GP
Boulares, H
Zhang, JH
Xu, M
Faden, AI
Citation: Ag. Yakovlev et al., Presence of DNA fragmentation and lack of neuroprotective effect in DFP45 knockout mice subjected to traumatic brain injury, MOL MED, 7(3), 2001, pp. 205-216
Authors:
Vink, R
Mullins, PGM
Temple, MD
Bao, WL
Faden, AI
Citation: R. Vink et al., Small shifts in craniotomy position in the lateral fluid percussion injurymodel are associated with differential lesion development, J NEUROTRAU, 18(8), 2001, pp. 839-847
Authors:
Yakovlev, AG
Ota, K
Wang, GP
Movsesyan, V
Bao, WL
Yoshihara, K
Faden, AI
Citation: Ag. Yakovlev et al., Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury, J NEUROSC, 21(19), 2001, pp. 7439-7446
Authors:
Movsesyan, VA
O'Leary, DM
Fan, L
Bao, WL
Mullins, PGM
Knoblach, SM
Faden, AI
Citation: Va. Movsesyan et al., mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and invivo by antagonizing N-methyl-D-aspartate receptors, J PHARM EXP, 296(1), 2001, pp. 41-47
Citation: Jw. Allen et al., Exacerbation of neuronal cell death by activation of group 1 metabotropic glutamate receptors: Role of NMDA receptors and arachidonic acid release, EXP NEUROL, 169(2), 2001, pp. 449-460
Authors:
Movsesyan, VA
Yakovlev, AG
Fan, L
Faden, AI
Citation: Va. Movsesyan et al., Effect of serine protease inhibitors on posttraumatic brain injury and neuronal apoptosis, EXP NEUROL, 167(2), 2001, pp. 366-375
Authors:
Faden, AI
O'Leary, DM
Fan, L
Bao, WL
Mullins, PGM
Movsesyan, VA
Citation: Ai. Faden et al., Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma, EXP NEUROL, 167(2), 2001, pp. 435-444
Citation: Md. Temple et al., The role of glutamate receptors in the pathophysiology of traumatic central nervous system injury, HEAD TRAUMA, 2001, pp. 87-113
Citation: Ba. Eldadah et al., Ribozyme-mediated inhibition of caspase-3 protects cerebellar granule cells from apoptosis induced by serum-potassium deprivation, J NEUROSC, 20(1), 2000, pp. 179-186
Authors:
Albensi, BC
Knoblach, SM
Chew, BGM
O'Reilly, MP
Faden, AI
Pekar, JJ
Citation: Bc. Albensi et al., Diffusion and high resolution MRI of traumatic brain injury in rats: Time course and correlation with histology, EXP NEUROL, 162(1), 2000, pp. 61-72
Citation: Gb. Fox et al., Behavioral responses of C57BL/6, FVB/N, and 129/SvEMS mouse strains to traumatic brain injury: Implications for gene targeting approaches to neurotrauma, J NEUROTRAU, 16(5), 1999, pp. 377-389
Citation: Jw. Allen et al., Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis, FASEB J, 13(13), 1999, pp. 1875-1882
Authors:
Faden, AI
Fox, GB
Fan, L
Araldi, GL
Qiao, LX
Wang, SM
Kozikowski, AP
Citation: Ai. Faden et al., Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents, AM J P-REG, 277(4), 1999, pp. R1196-R1204
Citation: Sm. Knoblach et al., Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment, J NEUROIMM, 95(1-2), 1999, pp. 115-125
Authors:
Feinklestein, SP
Fisher, M
Furland, AJ
Goldstein, LB
Gorelick, PB
Kaste, M
Lees, KR
Traystman, RJ
Albers, GW
Anwer, UE
Ashwood, T
Barone, FC
Basta, SL
Bogousslavsky, J
Buchan, AM
Cady, WJ
Chan, PH
Clemens, JA
Cox, BF
Craddock, RE
Cramer, SC
del Zoppo, GJ
Dielrich, WD
Elliott, P
Faden, AI
Feuerstein, GZ
Ginsberg, MD
Gold, M
Greene, WL
Hall, ED
Hsu, CY
Hunter, AJ
Lai, M
Lesko, LM
Levy, DE
Li, FH
Locke, KW
Lodge, D
Lowe, D
Marcoux, FW
McCulloch, J
McDermott, J
Meibach, R
Messersmith, EK
Moseley, M
Moskowitz, MA
Mueller, AL
Munro, F
Nudo, RJ
Oeda, J
Ohlstein, EH
Parsons, A
Patmore, L
Poole, RM
Pschorn, U
Pulsinelli, WA
Sacco, RL
Saeki, S
Salazar-Grueso, E
Sandage, BW
Schallert, T
Schielke, GP
Sharkey, J
Sotak, CH
Steiger, B
Storall, S
Takahashi, Y
Tumas, D
Van Bruggen, N
Versavel, M
Vornov, J
Walker, MD
Wallin, B
Wang, J
Warach, S
Wells, DS
Witcher, JA
Citation: Sp. Feinklestein et al., Recommendations for standards regarding preclinical neuroprotective and restorative drug development, STROKE, 30(12), 1999, pp. 2752-2758
Citation: Jw. Allen et al., beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: exacerbation by selective inhibition of group I metabotropic glutamate receptors, NEUROPHARM, 38(8), 1999, pp. 1243-1252
Authors:
Allen, JW
Ivanova, SA
Fan, L
Espey, MG
Basile, AS
Faden, AI
Citation: Jw. Allen et al., Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury, J PHARM EXP, 290(1), 1999, pp. 112-120